Key facts
- This page summarizes Seah H. Lim's Form 4 filing for Emmaus Life Sciences, Inc. (EMMA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 Sep 2024, 11:40.
Seah H. Lim - 16 Sep 2024 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)
- Reporting relationship
- Director
- Issuer ticker
- EMMA
- Reported as of
- 16 Sep 2024
- Net transaction value
- +$800
- SEC form
- 4
- Accepted by SEC
- 18 Sep 2024, 11:40:08 UTC
- Prior SEC filing
- 05 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- Seah H. Lim
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Seah H. Lim filed Form 4 for Emmaus Life Sciences, Inc. (EMMA) on 18 Sep 2024.
Change
- Previous filing in this sequence was filed on 05 Feb 2024.
- Current net transaction value: +$800.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EMMA
transaction
Common stock, $0.001 par value
Purchase
- Transaction value
- $800
- Shares
- +20,000
- Change %
- +0.44%
- Price
- $0.0400
- Shares after
- 4,606,626
- Date
- 16 Sep 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.